Anderson Harvey
Known title: Chief Legal Officer & SecCIK: 0001842375
Associated companies
Transaction History
| HPQ | ▼ Sell | Open Market | 8,939 | $329K | 2/15/2022 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 13,969 | $0 | 2/1/2022 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 5,030 | $188K | 2/1/2022 | View on chart |
| HPQ | ▼ Sell | Open Market | 10,934 | $397K | 12/10/2021 | View on chart |
| HPQ | ▼ Sell | Open Market | 8,268 | $298K | 12/9/2021 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 38,092 | $0 | 12/7/2021 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 18,890 | $704K | 12/7/2021 | View on chart |
| HPQ | ▼ Sell | Open Market | 17,166 | $654K | 12/3/2021 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 24,238 | $0 | 11/23/2021 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 9,591 | $309K | 11/23/2021 | View on chart |
| HPQ | ▼ Sell | Open Market | 7,811 | $244K | 11/2/2021 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 7,168 | $0 | 10/31/2021 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 2,479 | $75K | 10/31/2021 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 4,744 | $0 | 10/29/2021 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 1,652 | $50K | 10/29/2021 | View on chart |
| HPQ | ▲ Buy | Option Exercise | 3,852 | $0 | 10/29/2021 | View on chart |
| HPQ | ▼ Sell | Tax Withholding | 1,333 | $40K | 10/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
HPQ earnings beat followed by stock decline
HP reported earnings that exceeded analysts' expectations, marking a positive surprise for the quarter. Despite the beat, the shares fell more than the broader market, drawing fresh attention to the stock's recent weakness. The price is now near a long‑standing support level around $24.05, a point that has been tested many times.
HPQ earnings beat followed by stock decline. HP reported earnings that exceeded analysts' expectations, marking a positive surprise for the quarter. Despite the beat, the shares fell more than the broader market, drawing fresh attention to the stock's recent weakness. The price is now near a long‑standing support level around $24.05, a point that has been tested many times.